BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country.

Saved in:
Bibliographic Details
Title: BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country.
Authors: Abu Laban D; Department of Diagnostic radiology, King Hussein Cancer Center, Amman, Jordan., Alsharif A; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan., Al-Hussaini M; Department of Pathology, King Hussein Cancer Center, Amman, Jordan., Obeidat M; Department of Surgery, King Hussein Cancer Center, Amman, Jordan., Maraqa B; Department of Pathology, King Hussein Cancer Center, Amman, Jordan., Alzoubi Q; Department of Diagnostic radiology, King Hussein Cancer Center, Amman, Jordan., Musharbash A; Department of Surgery, King Hussein Cancer Center, Amman, Jordan., Jaddoua S; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan., Ramlawi R; Department of Nursing, King Hussein Cancer Center, Amman, Jordan., Khaleifeh K; Department of Nursing, King Hussein Cancer Center, Amman, Jordan., Ibrahimi AK; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Sarhan N; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Bouffet E; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada., Amayiri N; Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan.
Source: Frontiers in oncology [Front Oncol] 2024 Sep 27; Vol. 14, pp. 1417484. Date of Electronic Publication: 2024 Sep 27 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2024.1417484